Psychotropic & Addiction Drugs PNLE Questions
Introduction
The live Tangerine inventory contains 36 original PNLE-style practice questions focused on Psychotropic and Addiction Drugs. It gives learners practice with medication selection, patient teaching, adverse-effect recognition, therapeutic goals, and urgent safety decisions. The scope includes antidepressant, antipsychotic, anxiolytic, mood, and substance-use medications. Neurologic and Analgesic Drugs, Adverse Effects and Toxicology, and Special Populations Pharmacology are adjacent practice topics.
Use this topic to connect a medication with the clinical problem it is intended to address. A strong answer identifies the treatment goal, recognizes the most important cue, prioritizes immediate safety, and selects appropriate monitoring or teaching. The inventory was last updated August 12, 2026.
NP7: Pharmacology is a Tangerine cross-cutting practice area, not a separate official PNLE test subject. This lens is mapped across relevant competencies in the official five-subject PNLE TOS and should be interpreted alongside the 2025 Enhanced TOS. The official TOS provides broad competency relationships, not a guaranteed microtopic weight. Exact microtopic distribution varies by exam form.
Key concepts
- Match an antidepressant with its therapeutic goal and time course
Recognize: Antidepressant questions may test the intended outcome, such as reducing depressive symptoms or binge-purge symptoms when prescribed for bulimia nervosa. Therapeutic benefit may not be immediate, so early teaching and safety assessment matter.
Decide: Link the medication to the stated goal, reinforce adherence and follow-up, and assess for worsening mood or other urgent concerns.
Avoid: Do not label treatment ineffective solely because the patient does not feel better immediately or stop therapy without prescriber guidance. - Prevent MAOI-related hypertensive reactions
Recognize: MAOI questions often combine dietary teaching, medication reconciliation, and symptoms suggesting a dangerous blood-pressure response. New prescriptions, over-the-counter products, supplements, and certain foods require careful review.
Decide: Prioritize interaction prevention and urgent evaluation for severe headache, marked blood-pressure symptoms, or sudden neurologic changes.
Avoid: Do not treat MAOI teaching as a memorization exercise limited to one food list; the safety principle is avoiding preventable interactions. - Prioritize serious antipsychotic adverse effects
Recognize: Antipsychotic care may involve infection symptoms with clozapine, photosensitivity precautions, sedation, movement changes, and metabolic concerns with agents such as olanzapine.
Decide: Separate expected, reportable, and urgent findings, then follow the medication-specific monitoring plan. Fever or sore throat during clozapine therapy requires prompt attention.
Avoid: Do not dismiss a potentially serious finding as a routine medication effect or assume that all antipsychotics have identical risks. - Choose anxiolytic teaching based on the immediate safety problem
Recognize: Acute anxiety questions may focus on rapid symptom relief, while longer-term treatment requires attention to adherence, function, and adverse effects. Sedation and impaired coordination can affect safe activity.
Decide: Assess alertness, breathing, concurrent central nervous system depressants, and the patient’s ability to follow safety instructions before prioritizing medication administration or teaching.
Avoid: Do not select an anxiolytic merely because anxiety is named, and do not overlook dependence or misuse risk. - Connect mood-stabilizer therapy with the goal of controlling mania
Recognize: A mania vignette may describe reduced need for sleep, heightened activity, impaired judgment, or escalating behavior. The medication plan requires observation of response and drug-specific toxicity or adverse effects.
Decide: Prioritize safety, reduction of severe behavioral symptoms, ordered monitoring, and clear instructions about continuing therapy and reporting concerning changes.
Avoid: Do not judge success only by a single calm interaction or confuse sedation with complete stabilization. - Adapt psychotropic decisions to children and substance-use presentations
Recognize: ADHD medication questions may include appetite, sleep, behavior, caregiver teaching, and safe administration. Substance-use medication questions may require attention to withdrawal, craving, relapse prevention, concurrent depressants, or alcohol-related nutritional and neurologic concerns.
Decide: Identify the age, treatment goal, substance exposure, and immediate risk before selecting the priority assessment or teaching point.
Avoid: Do not apply an adult monitoring plan to a child or treat a substance-use presentation as a medication-choice problem without assessing safety. - Keep the psychotropic scope distinct from neurologic and analgesic pharmacology
Recognize: Seizure, migraine, and neurodegenerative medications belong in Neurologic and Analgesic Drugs, even when a drug affects mood or behavior.
Decide: Classify the medication and the central clinical problem before retrieving teaching points.
Avoid: Do not import a neurologic medication rule into a psychotropic question simply because the symptoms overlap.
What to expect on the PNLE
The 36-question inventory supports several PNLE-style forms: selecting medication for acute anxiety or mania, identifying a therapeutic goal, evaluating patient teaching, recognizing a serious adverse effect, and prioritizing action after an interaction or toxic response. It also includes boundary decisions involving children, alcohol-related presentations, photosensitivity, and medication-specific monitoring.
- Applying: 16 questions require using a medication principle in a patient situation.
- Remembering: 11 questions emphasize recall of a drug-related fact or safety point.
- Understanding: 6 questions test interpretation of a therapeutic purpose or teaching statement.
- Analyzing and evaluating: 2 questions require separating competing cues, while 1 asks for a higher-level judgment.
- Difficulty: The inventory contains 10 easy, 23 medium, and 3 hard questions.
These figures describe the supplied Tangerine inventory, not a guaranteed PNLE composition. Exact topic distribution varies by exam form. Use the 2025 Enhanced TOS to understand broad competency relationships, then use this lens to practice the clinical reasoning needed to connect medication, patient cue, therapeutic goal, and safety action.
Study tips
- Begin with diagnostic practice. Complete a short mixed set from this topic without notes. For every missed or guessed item, mark whether the problem was drug class, treatment goal, urgent adverse effect, interaction, monitoring, or patient teaching.
- Use focused retrieval with a comparison grid. Make a two-column or three-column table in your notes with these headings: medication group, intended clinical goal, and priority safety teaching. Add separate rows for antidepressants, antipsychotics, anxiolytics, mood medications, and substance-use medications. Include a final row for findings that need prompt reporting.
- Review the rationale and your error pattern. For each item, write the cue that controlled the decision and why the other options were less safe. Use a sequence of indication, expected outcome, immediate risk, monitoring, and teaching when rewriting the rationale in your own words.
- Retry with spaced retrieval. Hide your notes and explain each row of the grid at a later study session. Reattempt missed questions after a delay, then change the patient cue or medication goal in your notes to test whether you understand the principle rather than remember the answer position.
- Finish with mixed timed practice. Combine psychotropic questions with adjacent pharmacology topics only after focused review. Keep timing separate from learning: after the set, inspect whether a rushed choice ignored an interaction, a serious adverse effect, or the difference between symptom relief and the intended therapeutic goal.
Common mistakes to avoid
- Assuming an antidepressant has failed because benefit is not immediate.
The correcting cue is the medication’s therapeutic goal and expected time course. Review adherence, follow-up, and urgent mood or safety changes before concluding that the plan is ineffective. - Reducing MAOI teaching to a partial food list.
The safety principle is interaction prevention. Check prescribed drugs, over-the-counter products, supplements, and dietary teaching together, and prioritize urgent assessment when severe headache or marked blood-pressure symptoms appear. - Choosing an anxiolytic from the anxiety label alone.
First decide whether the question concerns acute relief, ongoing management, sedation risk, or misuse risk. Assess alertness, breathing, concurrent central nervous system depressants, and safe activity. - Calling every antipsychotic reaction routine.
Medication-specific cues change the priority. Infection symptoms during clozapine therapy, major movement changes, severe sedation, or significant metabolic concerns require more attention than ordinary patient discomfort. - Using one monitoring rule for every mood or ADHD medication.
Match monitoring to the drug, the patient’s age, the treatment goal, and the prescribed plan. For children, include caregiver teaching and observe appetite, sleep, behavior, and other relevant changes. - Ignoring the substance-use context.
Identify whether the priority is withdrawal safety, craving or relapse prevention, concurrent depressant exposure, or alcohol-related nutritional and neurologic risk. Medication teaching is safer when it follows that assessment.
Try a question
A real Psychotropic & Addiction Drugs question from our bank. Give it a shot.
A client taking a monoamine oxidase inhibitor (MAOI) for depression asks about dietary restrictions. The nurse explains that consuming foods high in tyramine while on this medication can lead to which serious complication?
Monoamine oxidase inhibitors (MAOIs) are a class of antidepressant medications that work by inhibiting the breakdown of neurotransmitters such as norepinephrine, serotonin, and dopamine. A critical and well-known interaction associated with MAOIs is their potential to cause a life-threatening hypertensive crisis when taken with foods high in tyramine.
Tyramine is an amino acid found in many aged, fermented, or pickled foods, including aged cheese, cured meats, soy products, and some alcoholic beverages. Normally, monoamine oxidase in the gastrointestinal tract breaks down excess tyramine, preventing it from entering the systemic circulation. When a client is on MAOI therapy, this enzyme is inhibited, leading to elevated tyramine levels if dietary intake is not restricted. The excess tyramine prompts a massive release of norepinephrine, which leads to severe vasoconstriction and sudden, dangerous elevation in blood pressure, known as a hypertensive crisis. Signs include severe headache, palpitations, neck stiffness, nausea, vomiting, sweating, and possible progression to intracranial hemorrhage or stroke if untreated.
| Option | Rationale |
|---|---|
| A. Hypertensive crisis | Correct. MAOIs block the normal breakdown of tyramine, resulting in excessive norepinephrine and potentially fatal acute hypertension when tyramine-rich foods are consumed. |
| B. Severe hypotension | Incorrect. MAOIs do not cause dangerous drops in blood pressure when taken with tyramine; the risk is actually severe hypertension, not hypotension. |
| C. Respiratory depression | Incorrect. While some psychotropic drugs can cause respiratory depression, this is not a direct risk with dietary tyramine and MAOIs. The primary risk is cardiovascular, not respiratory. |
| D. Hyperglycemia | Incorrect. There is no evidence that MAOIs or the tyramine interaction cause elevated blood sugar. This is not a relevant complication in this context. |
Nursing Implications:
- Educate clients on strict dietary restrictions when taking MAOIs, focusing on avoidance of high-tyramine foods.
- Assess clients regularly for signs of hypertensive crisis and intervene promptly if they develop symptoms.
- Reinforce the importance of medication and food interaction awareness as a priority in safe pharmacologic management for depression.
Clinical Pearl: Remember the association “MAOI = Must Avoid Old Ingredients (cheese, meats, beer)” as a mnemonic to recall key foods to avoid.
Understanding the mechanism of drug-food interactions with MAOIs is essential for client safety and is a frequently tested concept on nursing licensure exams.
Videbeck, S. L. (2011). Psychiatric-Mental Health Nursing (5th ed.). Lippincott Williams & Wilkins.
Silvestri, L. A. (2017). Saunders Comprehensive Review for the NCLEX-RN Examination (7th ed.). Elsevier.
More Psychotropic & Addiction Drugs questions
33 questions available. Sign up to practice all of them.
A patient with bulimia nervosa is prescribed fluoxetine as part of treatment. Which therapeutic effect should the nurse explain?
A nurse is caring for a patient in the ward who is showing signs of severe anxiety. The physician prescribes medication to help manage the symptoms. Which drug should the nurse expect to give?
A client with anxiety and depression has been taking sertraline for one week and reports no improvement. What is the most important information for the nurse to provide?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.